Adverum Biotechnologies, Inc.
Hedge Funds Holdings
Last updated:
Adverum Biotechnologies, Inc.‘s stocks are currently a part of 34 hedge funds’ portfolios, which represents 39.88% of the total amount of its stocks outstanding. This makes up a total of 39.58M shares of Adverum Biotechnologies, Inc.. Compared to the previous quarter, the number fell by -30.92% or -17.72M shares fewer. As for the holding position changes, 20.59% (7) of current hedge fund investors increased the number of shares held, 26.47% (9) of current holders sold a part of the shares held, and 14.71% (5) closed the holdings completely. 3 hedge funds are new holders of Adverum Biotechnologies, Inc. stock in Q1 2023, it is 8.82% of total holders.
Hedge funds holding Adverum Biotechnologies (Q2 2018 – Q1 2023)
| Q2 2018 | 100 |
|---|---|
| Q3 2018 | 101 |
| Q4 2018 | 85 |
| Q1 2019 | 83 |
| Q2 2019 | 94 |
| Q3 2019 | 99 |
| Q4 2019 | 115 |
| Q1 2020 | 125 |
| Q2 2020 | 141 |
| Q3 2020 | 158 |
| Q4 2020 | 153 |
| Q1 2021 | 131 |
| Q2 2021 | 117 |
| Q3 2021 | 107 |
| Q4 2021 | 95 |
| Q1 2022 | 87 |
| Q2 2022 | 71 |
| Q3 2022 | 74 |
| Q4 2022 | 59 |
| Q1 2023 | 34 |
Hedge funds changes in Adverum Biotechnologies positions (Q2 2018 – Q1 2023)
| Q2 2018 | 30 | 34 | 21 | 25 | -10 |
|---|---|---|---|---|---|
| Q3 2018 | 18 | 37 | 25 | 17 | 4 |
| Q4 2018 | 14 | 26 | 24 | 29 | -8 |
| Q1 2019 | 12 | 26 | 22 | 14 | 9 |
| Q2 2019 | 27 | 29 | 23 | 13 | 2 |
| Q3 2019 | 26 | 35 | 21 | 22 | -5 |
| Q4 2019 | 31 | 33 | 38 | 14 | -1 |
| Q1 2020 | 33 | 51 | 31 | 19 | -9 |
| Q2 2020 | 30 | 59 | 38 | 14 | 0 |
| Q3 2020 | 34 | 67 | 38 | 16 | 3 |
| Q4 2020 | 24 | 53 | 50 | 28 | -2 |
| Q1 2021 | 8 | 45 | 51 | 28 | -1 |
| Q2 2021 | 22 | 45 | 29 | 35 | -14 |
| Q3 2021 | 13 | 34 | 38 | 23 | -1 |
| Q4 2021 | 13 | 25 | 39 | 28 | -10 |
| Q1 2022 | 9 | 13 | 41 | 17 | 7 |
| Q2 2022 | 16 | 10 | 25 | 30 | -10 |
| Q3 2022 | 17 | 11 | 28 | 14 | 4 |
| Q4 2022 | 10 | 14 | 23 | 22 | -10 |
| Q1 2023 | 3 | 7 | 9 | 5 | 10 |
Hedge funds changes in Adverum Biotechnologies stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 823,500 | 187,000 |
|---|---|---|
| Q3 2018 | 818,250 | 237,000 |
| Q4 2018 | 54,000 | 52,000 |
| Q1 2019 | 0 | 4,000 |
| Q2 2019 | 1,227,000 | 869,000 |
| Q3 2019 | 6,524,000 | 6,682,000 |
| Q4 2019 | 11,942,000 | 3,694,000 |
| Q1 2020 | 11,597,000 | 1,139,000 |
| Q2 2020 | 14,879,000 | 5,101,000 |
| Q3 2020 | 6,642,000 | 4,633,000 |
| Q4 2020 | 7,152,000 | 11,826,000 |
| Q1 2021 | 2,874,000 | 12,294,000 |
| Q2 2021 | 3,339,000 | 4,266,000 |
| Q3 2021 | 2,725,000 | 2,052,000 |
| Q4 2021 | 2,013,000 | 1,118,000 |
| Q1 2022 | 689,000 | 321,000 |
| Q2 2022 | 452,000 | 13,000 |
| Q3 2022 | 333,000 | 10,000 |
| Q4 2022 | 241,765 | 6,781 |
| Q1 2023 | 0 | 0 |